For instance, although inclusion bodies are  a hallmark of disease in HD and Tar DNA binding protein 43 (TDP43) ALS, their presence appears to be more consistent with a coping mechanism rather than a causative factor, suggesting clinical intervention to inhibit inclusion body formation could be a misguided approach3,8. This evidence concerns the gene TARDBP and amyotrophic lateral sclerosis.